These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16170688)

  • 1. [Hypertrophic cardiomyopathy].
    Scheffold T; Binner P; Erdmann J; Schunkert H;
    Herz; 2005 Sep; 30(6):550-7. PubMed ID: 16170688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interventional treatment in hypertrophic cardiomyopathy].
    Gietzen FH; Schümmelfeder J; Neuser H; Brunn J; Schumacher B; Kerber S
    Herz; 2005 Mar; 30(2):102-10. PubMed ID: 15875098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy and risk-stratification in hypertrophic cardiomyopathy--a current survey].
    Reith S; Klues HG
    Z Kardiol; 2003 Apr; 92(4):283-93. PubMed ID: 12707787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of hypertrophic cardiomyopathies].
    Kühl C; Luedde M; Langer C; Frey N
    Dtsch Med Wochenschr; 2013 Mar; 138(12):583-8. PubMed ID: 23483418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertrophic cardiomyopathy: current aspects and new developments].
    Desnos M
    Bull Acad Natl Med; 2012; 196(4-5):997-1009; discussion 1009-10. PubMed ID: 23550458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of hypertrophic and dilated cardiomyopathy].
    Ikeda H; Imaizumi T
    Nihon Rinsho; 2000 Jan; 58(1):86-92. PubMed ID: 10885294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice. Hypertrophic obstructive cardiomyopathy.
    Nishimura RA; Holmes DR
    N Engl J Med; 2004 Mar; 350(13):1320-7. PubMed ID: 15044643
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy: etiology, diagnosis, and treatment.
    Ramaraj R
    Cardiol Rev; 2008; 16(4):172-80. PubMed ID: 18562807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment.
    Musat D; Sherrid MV
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():9-17. PubMed ID: 17162264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease.
    Charron P; Komajda M
    Expert Rev Mol Diagn; 2006 Jan; 6(1):65-78. PubMed ID: 16359268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertrophic cardiomyopathy: DNA diagnosis, genetic counselling and the risk of sudden cardiac death].
    Baars HF; Christiaans I; de Nijs PT; Cramer MJ; van Langen IM; Doevendans PA
    Ned Tijdschr Geneeskd; 2010; 154():A698. PubMed ID: 20132578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy: electrocardiographic manifestations and other important considerations for the emergency physician.
    Kelly BS; Mattu A; Brady WJ
    Am J Emerg Med; 2007 Jan; 25(1):72-9. PubMed ID: 17157688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midventricular obstruction and clinical decision-making in obstructive hypertrophic cardiomyopathy.
    Cecchi F; Olivotto I; Nistri S; Antoniucci D; Yacoub MH
    Herz; 2006 Dec; 31(9):871-6. PubMed ID: 17180650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
    Maron BJ; Maron MS; Lesser JR; Hauser RG; Haas TS; Harrigan CJ; Appelbaum E; Main ML; Roberts WC
    Am J Cardiol; 2008 Feb; 101(4):544-7. PubMed ID: 18312775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.